{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:51:35Z","timestamp":1792759895472,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T00:00:00Z","timestamp":1429228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00109-015-1277-z","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T20:47:59Z","timestamp":1429130879000},"page":"1095-1106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Curcumin nanoparticles inhibit corneal neovascularization"],"prefix":"10.1007","volume":"93","author":[{"given":"Nirparaj","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushovan","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Konar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbani","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,17]]},"reference":[{"key":"1277_CR1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","volume":"443","author":"BK Ambati","year":"2006","unstructured":"Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT et al (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443:993\u2013997","journal-title":"Nature"},{"key":"1277_CR2","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","volume":"103","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, Pytowski B, Persaud K, Wu Y, Streilein JW et al (2006) Proc Natl Acad Sci U S A 103:11405\u201311410","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1277_CR3","first-page":"18","volume":"39","author":"S Amano","year":"1998","unstructured":"Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP (1998) Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 39:18\u201322","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1277_CR4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D\u2019Amore PA, Dana MR, Wiegand SJ, Streilein JW (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040\u20131050","journal-title":"J Clin Invest"},{"key":"1277_CR5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00441-009-0908-5","volume":"339","author":"Y Gong","year":"2010","unstructured":"Gong Y, Koh DR (2010) Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res 339:437\u2013448","journal-title":"Cell Tissue Res"},{"key":"1277_CR6","first-page":"2514","volume":"41","author":"W Philipp","year":"2000","unstructured":"Philipp W, Speicher L, Humpel C (2000) Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 41:2514\u20132522","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1277_CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","volume":"82","author":"L Gan","year":"2004","unstructured":"Gan L, Fagerholm P, Palmblad J (2004) Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand 82:557\u2013563","journal-title":"Acta Ophthalmol Scand"},{"key":"1277_CR8","first-page":"274","volume":"38","author":"U Benelli","year":"1997","unstructured":"Benelli U, Ross JR, Nardi M, Klintworth GK (1997) Corneal neovascularization induced by xenografts or chemical cautery: inhibition by cyclosporin A. Invest Ophthalmol Vis Sci 38:274\u2013282","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1277_CR9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF00947067","volume":"235","author":"A Hayashi","year":"1997","unstructured":"Hayashi A, Popovich KS, Kim HC, de Juan E (1997) Role of protein tyrosine phosphorylation in rat corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 235:460\u2013467","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1277_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43:245\u2013269","journal-title":"Surv Ophthalmol"},{"key":"1277_CR11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/jop.2012.0158","volume":"29","author":"L Gonzalez","year":"2013","unstructured":"Gonzalez L, Loza RJ, Han KY, Sunoqrot S, Cunningham C, Purta P, Drake J, Jain S, Hong S, Chang JH (2013) Nanotechnology in corneal neovascularization therapy\u2014a review. J Ocul Pharmacol Ther 29:124\u2013134","journal-title":"J Ocul Pharmacol Ther"},{"key":"1277_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000111158","volume":"40","author":"AA Sarchahi","year":"2008","unstructured":"Sarchahi AA, Maimandi A, Tafti AK, Amani M (2008) Effects of acetylcysteine and dexamethasone on experimental corneal wounds in rabbits. Ophthalmic Res 40:41\u201348","journal-title":"Ophthalmic Res"},{"key":"1277_CR13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0161-6420(00)00538-8","volume":"108","author":"AC Guidera","year":"2001","unstructured":"Guidera AC, Luchs JI, Udell IJ (2001) Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 108:936\u2013944","journal-title":"Ophthalmology"},{"key":"1277_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/187221309789257450","volume":"3","author":"Y Shakiba","year":"2009","unstructured":"Shakiba Y, Mansouri K, Rezaei N, Arshadi D (2009) Corneal neovascularization: molecular events and therapeutic options. Recent Patents Inflamm Allergy Drug Discov 3:221\u2013231","journal-title":"Recent Patents Inflamm Allergy Drug Discov"},{"key":"1277_CR15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","volume":"31","author":"Y Koenig","year":"2012","unstructured":"Koenig Y, Bock F, Kruse FE, Stock K, Cursiefen C (2012) Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs. Cornea 31:887\u2013892","journal-title":"Cornea"},{"key":"1277_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ophtha.2008.02.013","volume":"115","author":"SW Kim","year":"2008","unstructured":"Kim SW, Ha BJ, Kim EK, Tchah H, Kim TI (2008) The effect of topical bevacizumab on corneal neovascularization. Ophthalmology 115:33\u201338","journal-title":"Ophthalmology"},{"key":"1277_CR17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/ICO.0b013e31819839f9","volume":"28","author":"JY Oh","year":"2009","unstructured":"Oh JY, Kim MK, Wee WR (2009) Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy. Cornea 28:1070\u20131073","journal-title":"Cornea"},{"key":"1277_CR18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1167\/iovs.02-0685","volume":"44","author":"BK Ambati","year":"2003","unstructured":"Ambati BK, Anand A, Joussen AM, Kuziel WA, Adamis AP, Ambati J (2003) Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol Vis Sci 44:590\u2013593","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1277_CR19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00003226-200307000-00013","volume":"22","author":"BK Ambati","year":"2003","unstructured":"Ambati BK, Joussen AM, Anand A, Adamis AP, Ambati J (2003) Inhibition of corneal neovascularization by genetic ablation of CCR2. Cornea 22:465\u2013467","journal-title":"Cornea"},{"key":"1277_CR20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/ICO.0b013e3181930bcd","volume":"28","author":"P Lu","year":"2009","unstructured":"Lu P, Li L, Liu G, van Rooijen N, Mukaida N, Zhang X (2009) Opposite roles of CCR2 and CX3CR1 macrophages in alkali-induced corneal neovascularization. Cornea 28:562\u2013569","journal-title":"Cornea"},{"key":"1277_CR21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","volume":"10","author":"W Lan","year":"2012","unstructured":"Lan W, Petznick A, Heryati S, Rifada M, Tong L (2012) Nuclear factor-kB: central regulator in ocular surface inflammation and diseases. Ocul Surf 10:137\u2013148","journal-title":"Ocul Surf"},{"key":"1277_CR22","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.3892\/mmr.2014.3079","volume":"11","author":"F Zhao","year":"2015","unstructured":"Zhao F, Gong Y, Hu Y, Lu M, Wang J, Dong J, Chen D, Chen L, Fu F, Qiu F (2015) Curcumin and its major metabolites inhibit the inflammatory response induced by lipopolysaccharide: translocation of nuclear factor-\u03baB as potential target. Mol Med Rep 11:3087\u20133093","journal-title":"Mol Med Rep"},{"key":"1277_CR23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","volume":"26","author":"R Gaudana","year":"2009","unstructured":"Gaudana R, Jwala J, Boddu SH (2009) Recent perspectives in ocular drug delivery. Pharm Res 26:1197\u20131216","journal-title":"Pharm Res"},{"key":"1277_CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH, Gabison EE, Kato T (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242\u2013249","journal-title":"Curr Opin Ophthalmol"},{"key":"1277_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/02713683.2011.652286","volume":"37","author":"M Rawas-Qalaji","year":"2012","unstructured":"Rawas-Qalaji M, Williams CA (2012) Advances in ocular drug delivery. Curr Eye Res 37:345\u2013356","journal-title":"Curr Eye Res"},{"key":"1277_CR26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2217\/nnm.12.175","volume":"8","author":"R Guha","year":"2013","unstructured":"Guha R, Chowdhury S, Palui H, Mishra A, Basak S, Mandal TK, Hazra S, Konar A (2013) Doxorubicin-loaded MePEG-PCL nanoparticles for prevention of posterior capsular opacification. Nanomedicine (Lond) 8:1415\u20131428","journal-title":"Nanomedicine (Lond)"},{"key":"1277_CR27","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1167\/iovs.11-9139","volume":"53","author":"Y Qazi","year":"2012","unstructured":"Qazi Y, Stagg B, Singh N, Singh S, Zhang X, Luo L, Simonis J, Kompella UB, Ambati BK (2012) Nanoparticle-mediated delivery of shRNA. VEGF-A plasmids regresses corneal neovascularization. Invest Ophthalmol Vis Sci 53:2837\u20132844","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1277_CR28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12272-009-1417-5","volume":"32","author":"AM Al-Abd","year":"2009","unstructured":"Al-Abd AM, Kim NH, Song SC, Lee SJ, Kuh HJ (2009) A simple HPLC method for doxorubicin in plasma and tissues of nude mice. Arch Pharm Res 32:605\u2013611","journal-title":"Arch Pharm Res"},{"key":"1277_CR29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000126081","volume":"222","author":"F Bian","year":"2008","unstructured":"Bian F, Zhang MC, Zhu Y (2008) Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo. Ophthalmologica 222:178\u2013186","journal-title":"Ophthalmologica"},{"key":"1277_CR30","first-page":"1185","volume":"8","author":"R Klein","year":"1976","unstructured":"Klein R, Lobes LA Jr (1976) Ocular alkali burns in a large urban area. Ann Ophthalmol 8:1185\u20131189","journal-title":"Ann Ophthalmol"},{"key":"1277_CR31","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/bjo.71.11.854","volume":"71","author":"SJ Morgan","year":"1987","unstructured":"Morgan SJ (1987) Chemical burns of the eye: causes and management. Br J Ophthalmol 71:854","journal-title":"Br J Ophthalmol"},{"key":"1277_CR32","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0960-894X(98)00331-X","volume":"8","author":"FC Huang","year":"1998","unstructured":"Huang FC, Chan WK, Moriarty KJ (1998) Novel cytokine release inhibitors. Part I: triterpenes. Bioorg Med Chem Lett 8:1883\u20131886","journal-title":"Bioorg Med Chem Lett"},{"key":"1277_CR33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/02713680903528345","volume":"35","author":"JS Kim","year":"2010","unstructured":"Kim JS, Choi JS, Chung SK (2010) The effect of curcumin on corneal neovascularization in rabbit eyes. Curr Eye Res 35:274\u2013280","journal-title":"Curr Eye Res"},{"key":"1277_CR34","doi-asserted-by":"crossref","first-page":"44965","DOI":"10.1074\/jbc.M111.294967","volume":"286","author":"JM Sivak","year":"2011","unstructured":"Sivak JM, Ostriker AC, Woolfenden A, Demirs J, Cepeda R, Long D, Anderson K, Jaffee B (2011) Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization. J Biol Chem 286:44965\u201344975","journal-title":"J Biol Chem"},{"key":"1277_CR35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000055693","volume":"33","author":"DH Ma","year":"2001","unstructured":"Ma DH, Chen JK, Kim WS, Hao YX, Wu HC, Tsai RJ, Hwang DG, Zhang F (2001) Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularisation. Ophthalmic Res 33:353\u2013362","journal-title":"Ophthalmic Res"},{"key":"1277_CR36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF03401744","volume":"4","author":"JL Arbiser","year":"1998","unstructured":"Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4:376\u2013383","journal-title":"Mol Med"},{"key":"1277_CR37","first-page":"499","volume":"26","author":"C Gao","year":"2003","unstructured":"Gao C, Ding Z, Liang B, Chen N, Cheng D (2003) Study on the effects of curcumin on angiogenesis. Zhong Yao Cai 26:499\u2013502","journal-title":"Zhong Yao Cai"},{"key":"1277_CR38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/jop.2010.0123","volume":"27","author":"SK Gupta","year":"2011","unstructured":"Gupta SK, Kumar B, Nag TC (2011) Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 27:123\u2013130","journal-title":"J Ocul Pharmacol Ther"},{"key":"1277_CR39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, New-man RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807\u2013818","journal-title":"Mol Pharm"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-015-1277-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-015-1277-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-015-1277-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T10:35:35Z","timestamp":1566556535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-015-1277-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,17]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1007\/s00109-015-1277-z","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,17]]}}}